Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease.

Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease. Gastroenterology. 1999 Jul; 117(1):58-64.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.